報價延遲最少15分鐘:2025/01/21 08:53 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-27.81/3.30
|
|
企業價值
5.25B
|
| 資產負債 |
|
每股賬面淨值
47.38
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
3.00B
|
|
每股收益
46.41
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:53 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America. |